16667 Hymus Boulevard
Kirkland, QC H9H 4R9
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 100
|Mr. Steven Saviuk CA||Vice Chairman & CEO||259.34k||N/A||1959|
|Mr. Frederic Fasano||Pres, COO & Director||281.31k||N/A||1968|
|Mr. Luc Mainville M.B.A, M.B.A.||Sr. VP & CFO||283.6k||N/A||1964|
|Mr. Guy-Paul Allard||VP of Legal Affairs & Corp. Sec.||N/A||N/A||N/A|
|Ms. Michelle Brien||VP of HR & Talent Management||N/A||N/A||N/A|
|Ms. Nelly Komari||Sr. VP of Scientific & Medical Affairs||N/A||N/A||N/A|
|Mr. Frederic Dumais||Director of Communications & Investor Relations||N/A||N/A||N/A|
Valeo Pharma Inc., a specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceutical products with primary focus on respiratory, speciality, and hospital generic products in Canada. Its product portfolio includes Enerzair Breezhaler, an LABA/LAMA/ICS fixed triple dose asthma drug; Atectura Breezhaler, an LABA/ICS dual combination asthma drug; Redesca, to treat and prevent deep vein thrombosis and pulmonary embolism; Onstryv, Idiopathic Parkinson's Disease (PD) as an add-on for patients on stable dose of Levodopa alone or in combination with other drugs; M-Eslon, extended-release morphine sulphate used for pain management; and Yondelis, a soft tissue sarcoma. In addition, it offers Hesperco, bioflavonoid antioxidant used for immune support; Ametop, for skin Anesthesia prior to venepuncture or venous cannulation; Benztropine, an VPI-Anticholinergic agent used for the treatment of PD; Ethacrynate Sodium, a loop diuretic for high blood pressure and associated swelling; and Amikacin, an injectable antibiotic. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.
Valeo Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.